A new Texas law that will provide up to $50 million to study ibogaine reflects growing government interest in psychedelic therapy research for mental health treatments.

Unlike with opioids, there is no medication to suppress cravings for meth and other stimulants. As use soars, hundreds of clinics are trying a radically different approach.

Strong collaboration between physicians and SUD treatment programs provides continuity of care, an essential factor in SUD treatment outcomes.

How can we blend traditional telehealth sessions with smartphone applications while addressing digital literacy barriers to create more accessible and effective mental health treatment for all ...